Dendritic cells are specialized antigen-presenting cells that play a dual role in induction of
both innate and adaptive immunity as well as T cell tolerance. Dendritic cell based vaccines …

Dendritic cell (DC) immunotherapy has shown significant promise in animal studies as a
potential treatment for cancer. Its application in the clinic depends on the results of human …

A novel approach to vaccination against cancer is to exploit dendritic cells (DCs) as 'nature's
adjuvants' and actively immunize cancer patients with a sample of their own DCs primed …

[Frontiers in Bioscience 16, 2233-2242, June 1, 2011] 2233 Dramatic improvement of DC-based
immunotherapy against various malign Page 1 [Frontiers in Bioscience 16, 2233-2242, June 1 …

For many cancers the use of conventional chemotherapy has been maximized, and further
intensification of chemotherapy generally results in excess toxicity with little long-term …

Dendritic cells (DCs) are professional antigen-presenting cells and are frequently used in
current immunotherapy protocols. The administration of DCs loaded with tumor-associated …

Dendritic cells (DCs) are considered a very promising arm to activate the immune system in
immunotherapeutic strategies against cancer. DCs are the most powerful antigen-presenting …

Dendritic cell (DC) vaccine has been demonstrated to induce antitumor immunity in animal
models. It has been shown that the efficiency of antitumor immunity by DC vaccine is closely …

Dendritic cells (DCs) are the most potent professional antigen-presenting cells with exquisite
capacity to interact with T cells and initiate their responses; the antigen-presenting …

Since the first reported clinical trial of Dendritic Cell Vaccine (DCV) in cancer in the mid
nineties, few hundred clinical trials have been initiated and it was projected that over 3000 …